Evidence map›Paper›PMID 29362599›Full record

Trial reportJournal of medicine and life

Effect of Dialyzable Leukocyte Extract on chronic cervicitis in patients with HPV infection.

M P Acosta-Rios, E Sauer-Ramírez, L J Castro-Muñoz, M García-Solís, C Gómez-García, R Ocadiz-Delgado, A Martinez-Martinez, V Sánchez-Monroy, C Pérez-De la Mora, B Correa-Meza and 1 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medicine and life. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

M P Acosta-RiosPLaboratory of Molecular Biomedicine I, ENMyH, Instituto Politécnico Nacional, Mexico.
E Sauer-RamírezMexican College of Obstetrics and Gynecology Specialists, A.C. Mexico.
L J Castro-MuñozPLaboratory of Molecular Biomedicine I, ENMyH, Instituto Politécnico Nacional, Mexico.
M García-SolísHospital General de Milpa Alta, Mexico City SSA, Mexico.
C Gómez-GarcíaPLaboratory of Molecular Biomedicine I, ENMyH, Instituto Politécnico Nacional, Mexico.
R Ocadiz-DelgadoDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados IPN, Mexico.
A Martinez-MartinezDepartment of Chemical and Biological Sciences, Universidad Autónoma de Ciudad Juarez, Mexico.
V Sánchez-MonroyPLaboratory of Molecular Biomedicine I, ENMyH, Instituto Politécnico Nacional, Mexico.
C Pérez-De la MoraFARMAINMUNE, Azcapotzalco Mexico.
B Correa-MezaBIOXPORT, Azcapotzalco Mexico.
D G Perez-IshiwaraPLaboratory of Molecular Biomedicine I, ENMyH, Instituto Politécnico Nacional, Mexico.
Instituto Politécnico Nacional · MXDermatology Specialists · USHospital General de México · MXInstituto de Estudios Avanzados · VEUniversidad Autónoma de Ciudad Juárez · MXUniversidad Autónoma Metropolitana · MXUniversidad Azteca · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the study was to assess the clinical, histopathological and immunochemical changes induced by dialyzable leukocyte extract (DLE) treatment in patients with chronic cervicitis associated to HPV infection. Fifty-four female Mexican patients diagnosed with chronic cervicitis, cervical intra-epithelial neoplasia grade 1 (CIN 1) and HPV infection were divided into two groups: patients treated with placebo and patients treated with DLE. Clinical and colposcopy evaluations were performed before and after treatments. Cervix biopsies were obtained to analyze histopathological features and to determine the local immunological changes by immunohistochemistry analyses. Placebo-treated patients showed no significant changes in the evaluated parameters. Interestingly, in DLE-treated patients, clinical manifestations of cervicitis diminished and 89% of them remitted the colposcopic lesions. Histological analyses of biopsies from DLE-treated patients showed a decreasing leukocyte infiltrate. Immunochemical analyses showed an increased expression of TGF-β, while expression of IFN-γ, PCNA, and IL-32 decreased. Our results suggest that DLE can stimulate innate immunity of cervical mucosae, diminishing chronic cervicitis in HPV-infected patients.

trial registrationRegister ISRCTN16429164

Indexed as

AdultAgedBiopsyCervix UteriChronic DiseaseColposcopyFemaleHumansImmunohistochemistryInterferon-gammaInterleukinsMiddle AgedPapillomavirus InfectionsProliferating Cell Nuclear AntigenTransfer FactorTransforming Growth Factor betaIL32 protein, humanInterferon-gammaInterleukinsProliferating Cell Nuclear AntigenTransfer FactorTransforming Growth Factor betachronic cervicitisDLEHPV

Identifiers

PMID29362599
PMCPMC5771637
OpenAlexW2973028312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.